Nepal Khabar Online February 14, 2021

Pakistan approved fourth COVID-19 vaccine for its people. Pakistan approved its use as an emergency, making it the fourth drug to be cleared by the authority to hold the deadly virus. Chinese company Cansino Biologics Inc’s vaccine was approved by the Drug Regulatory Authority of Pakistan (DRAP) on Friday. Drap officials said that after its approval for emergency use, the supply of the doses will start in a few weeks. Previous Cansino Bio is the only vaccine for which Pakistan conducted a clinical trial with 18,000 volunteer. Spokesperson from Ministry of National Health Services, Sajid Shah said that” the decision was taken considering the results of the trials. So far, four vaccines – Sinophram (China), Oxford-AstraZeneca (UK), Sputnik-V (Russia) and Cansino Bio (China)- have been registered. This will make it easy to arrange the vaccine for such a large population to create hear immunity”.

Leave a comment.

Your email address will not be published. Required fields are marked*